Skip to main content
OpenTrials
Completed

NCT Number: NCT00655720

The Effects on Growth of a Non-Routine Infant Formula

A study to evaluate the growth and development of term infants fed either an extensively hydrolyzed formula with probiotics, a partially hydrolyzed formula with probiotics, or an extensively hydrolyzed formula without probiotics

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

12 day–16 day

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Term infant
  • Solely formula fed
  • 14 days of age

Exclusion criteria

  • History of underlying disease
  • Evidence of formula intolerance
  • Current illness

Treatment and study plan

Infant Formula

Other
  • hydrolyzed infant formula without probiotics
  • hydrolyzed infant formula with probiotics
  • hydrolyzed infant formula with probiotics

Other names: no other names for any of the intervention arms

Primary outcomes

  1. Growth (weight)

    Time frame: 106 days

Secondary outcomes

  1. Tolerance

    Time frame: 106 days

Sponsors and collaborators

Lead sponsor

Mead Johnson Nutrition

Industry

Registry information

Official study title

The Effects on Growth and Tolerance of Hydrolyzed Formulas Fed to Term Infants

Important dates

Study start
2006
Primary completion
2007
Study completion
2007
First posted
Apr 10, 2008
Registry last updated
Apr 15, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.